Clinical Trials
-
Brief Behavioral Intervention for Insomnia During Chemotherapy
Stanford is currently not accepting patients for this trial. -
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Stanford is currently not accepting patients for this trial. -
North American Prodromal Synucleinopathy Consortium
Stanford is currently accepting patients for this trial. -
SAR231893-LPS15497- "Dupilumab Effect on Sleep in AD Patients"
Stanford is currently accepting patients for this trial. -
Treatments for Insomnia: Mediators, Moderators and Quality of Life
Stanford is currently accepting patients for this trial. -
Treatment of REM Sleep Behavior Disorder (RBD) With Sodium Oxybate
Stanford is currently accepting patients for this trial. -
Natural History Study of Synucleinopathies
Stanford is currently accepting patients for this trial. -
Once-Nightly Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy
Stanford is currently accepting patients for this trial. -
Examination of the Effectiveness of Suvorexant in Improving Daytime Sleep in Shift Workers
Stanford is currently accepting patients for this trial. -
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
Stanford is currently accepting patients for this trial. -
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Stanford is currently accepting patients for this trial. -
Efficacy and Safety of Tasimelteon Compared With Placebo in Totally Blind Subjects With Non-24-Hour Sleep-Wake Disorder
Stanford is currently accepting patients for this trial.
Sleep and Oxygen Levels
Makoto Kawai, MD, D.Sc.
Purpose: to participate in groundbreaking research examining sleep and measures of brain oxygen levels simultaneously.
Payment offered for participation
Time needed from participant:
- Spend 6-8 hours of active participation
- You will be asked to complete one sleep assessment (polysomnography)
To qualify, you must:
- Be a healthy individual, 60+ years old
- Be able to travel to Stanford to complete some questionnaires
Coordinator Contact:
Isabelle Cotto (650) 723-2795
ijoly@Stanford.edu
Upper Airway Training for OSA
Clete Kushida, MD, PhD
Purpose: To see if playing a musical instrument-training program can improve OSA
Inclusion:
- 21-50 years old
- Diagnosis of mild to moderate OSA
- HST scheduled or recently performed
Time needed from participant: Approximately 12 weeks depending on OSA severity
Coordinator Contact:
Adrian Ekelmans (650) 721-5489
SUVN-G3031 for Narcolepsy 1 or 2
Emmanuel Mignot, MD, PhD
Purpose: To study the safety and efficacy of study drug SUVN-G3031 as a possible treatment for NT1 and NT2
Inclusion:
- 18-50 years old
- Diagnosis of narcolepsy type 1 or 2
- MSLT within 15 years showing ≤ 8 minutes with 2 or more SOREMPs
- An ESS score of ≥ 12
Time needed from participant: Up to 7 weeks of active participation. At least 5 clinic visits during that period
Coordinator Contact:
Vivian Liu (650) 721-5489
For more information: https://www.ClinicalTrials.gov
Participant’s right questions, contact: 1-866-680-2906